Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089427
Status:
COMPLETED
Last Update Posted:
2011-07-04
First Post:
2004-08-05
Brief Title:
IL13-PE38QQR Infusion After Tumor Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Sponsor:
INSYS Therapeutics Inc
Organization:
INSYS Therapeutics Inc
Organization Data
Organization:
INSYS Therapeutics Inc
Class:
INDUSTRY
Study ID:
IL13PEI-106-R01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
INSYS Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None